激光心肌血运重建辅助冠脉旁路移植治疗严重冠心病的研究

doi:10.3969/j.issn.1000-8535.2020.03.007

广州医药 ›› 2020, Vol. 51 ›› Issue (3): 31-35.DOI: 10.3969/j.issn.1000-8535.2020.03.007

激光心肌血运重建辅助冠脉旁路移植治疗严重冠心病的研究

朱玮, 黄伯湘, 郑远, 林冬群, 陈静薇, 林宇, 阮新民, 胡佳心

广东省中医院大学城医院心血管二科(广州 510106)

收稿日期:2020-02-27 出版日期:2020-05-20 发布日期:2021-11-28

Study of coronary artery bypass combined transmyocardial laser revascularization of severe coronary artery disease

ZHU Wei, HUANG Boxiang, ZHENG Yuan, LIN Dongqun, CHEN Jingwei, LIN Yu, RUAN Xinming, HU Jiaxin

Second Cardiovascular Department, Guangdong Province Hospital of Traditional Chinese Medicine,Guangzhou 510106,China

Received:2020-02-27 Online:2020-05-20 Published:2021-11-28

摘要/Abstract

摘要： 目的探讨激光心肌血运重建(Transmyocardial Laser revascularization, TMLR)辅助冠状动脉旁路移植术治疗严重冠心病的临床疗效及 11年随访结果。方法 25例严重冠心病患者行不停跳冠状动脉旁路移植术(off-pump coronary artery bypass, OPCAB)并辅以激光心肌血运重建术(TMLR组),回顾性总结了其术前、术中、术后及 11年随访资料,并与同期进行的 95例单纯不停跳冠状动脉旁路移植术(OPCAB组)病人资料进行比较分析。结果 TMLR组在平均远端吻合口数比 OPCAB组少,而手术时间、术后硝普钠用量比OPCAB组多,其他如术后机械通气时间、ICU停留时间、术后住院天数和术后常见并发症,2组之间均无差异;平均 11年随访资料中,胸闷痛、心衰、新出现 ST-T改变发生率、再发急性心梗、再次 PCI处理、LVEF和血管桥闭塞率,2组间无明显区别;死亡率二者之间也没有区别。结论 TMLR术辅助冠状动脉旁路移植术虽然手术时间比较长,血管活性药物应用较多,但术后康复和 11年随访资料显示与单纯 OPCAB术有相似的结果,说明 TMLR术作为冠状动脉旁路移植术的补充,对那些冠脉血管细小且钙化狭窄严重而不适合冠状动脉旁路移植术的冠心病患者是获益的。

关键词: 不停跳冠脉搭桥术, 激光心肌血运重建术, 术后随访

Abstract: Objective To explore and analyze the clinical effect of off-pump coronary artery bypass (OPCAB) combined transmyocardial laser revascularization(TMLR) of severe coronary artery disease and 11 years follow-up. Methods 25 cases with sever coronary artery disease were treated through OPCAB and TMLR, and the clinical data and 11 years follow-up data were summarized and analyzed retrospectively, compared with the data of the patients treated by only OPCAB. Results There were less mean bypass graft numbers in TMLR group than in OPCAB group. Operation time and the amount of sodium nitroprusside in TMLR group were more than that in OPCAB group. But intubation time, ICU stay time, postoperative stay time and postoperative common complications were not different between two groups. 11 years postoperative follow-up results indicated that chest pain, heart disfunction, ST-T alteration, AMI, PCI treatment again, LVEF and bypass graft occlusion rate were not obviously between two groups. Conclusion TMLR combined OPCAB may result in good outcome and improve long term survival.

Key words: Off-pump coronary artery bypass, Transmyocardial laser revascularization, Long term follow-up

朱玮, 黄伯湘, 郑远, 林冬群, 陈静薇, 林宇, 阮新民, 胡佳心. 激光心肌血运重建辅助冠脉旁路移植治疗严重冠心病的研究[J]. 广州医药, 2020, 51(3): 31-35.

ZHU Wei, HUANG Boxiang, ZHENG Yuan, LIN Dongqun, CHEN Jingwei, LIN Yu, RUAN Xinming, HU Jiaxin. Study of coronary artery bypass combined transmyocardial laser revascularization of severe coronary artery disease[J]. Guangzhou Medical Journal, 2020, 51(3): 31-35.

参考文献

[1] 何劲松,刘婧,白法文,等. 冠状动脉粥样硬化性心脏病患者 PCI 术后胸痛的研究进展[J]. 医学综述,2011,17(16): 2461-2463.
[2] STEG P G, JAMES S K, ATAR D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation [J]. Eur Heart J, 2012, 33(20): 2569-2619.
[3] 高立建,陈纪林. 急性冠状动脉综合征介入治疗最新进展[J]. 中国循环杂志,2013,28(1):5-7.
[4] HU S S, XIONG H, ZHENG Z, et al. Midterm outcomes of simultaneous hybrid coronary artery revascularization for left main coronary artery deisease[J]. Heart Surg Forum, 2012, 15(1): E18-22.
[5] 葛均波. 冠心病介入治疗的过去、现在和未来[J]. 遵义医学院学报,2014,37(1): 1-5.
[6] BEEK J F, van DER SLOOT J A, HUIKESHOVEN M, et al. Cardiac denervation after transmyocardial laser revascularization: short-term and long-term iodine 123-labeled meta-iodobenzyguanide scintigraphic evidence[J]. J Thorac Cardiovasc Surg, 2004,127(2):517-524.
[7] STONE G W, TEIRSTEIN P S, RUBENSTEIN R, et al. A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patient with nonrecanalizable chronic total occlusions[J]. J Am Coll Cardila, 2002, 39(10):1581-1587.
[8] 照日格吐. 激光心肌血运重建术联合微创小切口冠状动脉搭桥术治疗冠心病疗效观察[J]. 中国基层医药,2012,19(24): 3703-3704.
[9] FRAZIER O H, MARCH R J, HORVATH K A. Transmyocardial revascularization with a carbon dioxide laser in patients with end stage coronary disease[J]. N Engl J Med, 1999(341):1021-1028.
[10] HORVATH K A, COHN L H, COOLY D A, et al. Transmyocardial laser revascularization: results of a multicenter trial transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease[J]. J Thorac Cardiovasc Surg, 1997(113):645-654.
[11] de CARLO M, MILANO A, PRATALI S, et al. Symptomatic improvement after transmyocardial laser revascularization: how long does it last? [J]. Thorac Surg, 2000 (70):1130-1133.
[12] 林宇,周汉槎,阮新民,等. 不停跳冠状动脉搭桥结合心肌激光血运重建术治疗严重冠心病的初步探讨[J]. 岭南心血管病杂志,2004,10(2):119-122.
[13] ALLEN K B, DOWLING R D, ANGELL W W, et al. Transmyocardial revascularization: 5 year follow-up of a prospective, randomized multicenter trial[J]. Ann Thorac Surg,2004(77):1228-1234.
[14] 屈正,郑居兵,张兆光,等. 激光心肌血运重建术后 5 年随访[J]. 中华胸心血管外科杂志,2007,23(2):131-132.

激光心肌血运重建辅助冠脉旁路移植治疗严重冠心病的研究

Study of coronary artery bypass combined transmyocardial laser revascularization of severe coronary artery disease

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价